| BCBS South Dakota Medical Policies | Autologous Chondrocyte Implant for Focal Articular Cartilage Lesions | 2026-07-01 |
| BCBS South Dakota Medical Policies | Bio-Engineered Skin and Soft Tissue Substitutes | 2026-07-01 |
| HealthPartners | Aducanumab (Aduhelm™) and lecanemab (Leqembi® | 2026-07-01 |
| HealthPartners | Amyloid monoclonal antibodies | 2026-07-01 |
| HealthPartners | Anifrolumab (Saphnelo®) and belimumab (Benlysta®) | 2026-07-01 |
| HealthPartners | Biologics for allergy and pulmonology | 2026-07-01 |
| HealthPartners | Biologics for chronic inflammatory diseases | 2026-07-01 |
| HealthPartners | Biologics requiring IV induction dosing | 2026-07-01 |
| HealthPartners | Blood factor and non-factor products for hemophilia | 2026-07-01 |
| HealthPartners | Burosumab (Crysvita®) | 2026-07-01 |